Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
160.4 USD | -0.06% | -0.15% | +3.61% |
09:44am | Medincell: share price rises on resumption of trading | CF |
05-08 | AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.61% | 283B | |
+32.85% | 698B | |
+26.51% | 568B | |
-4.57% | 358B | |
+19.37% | 328B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.81% | 165B | |
-2.41% | 160B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie, Genmab Lymphoma Treatment Receives Priority Review by FDA for New Indication